Interestingly, topoisomerase inhibition has been shown to downregulate AURKA expression, which may explain why most are predicted by scFOCAL and in vivo to be less discordant with alisertib-resistant GBM cells66. The gene discussed is AURKA; the disease is glioblastoma.